This week, I’m rerunning some popular posts while I put the finishing touches on DCI’s 2025-26 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. Click here to see the original post from June 2025. --- The 340B Drug Pricing Program has emerged as a growing source of profits for pharmacies and pharmacy benefit managers (PBMs). Drug Channels Institute’s latest exclusive analysis of the 2025 market reveals a highly concentrated market structure increasingly dominated...| Drug Channels
The establishment of well-intentioned programs that fail to achieve their objectives and waste taxpayer dollars is an unfortunately frequent occurrence in the| Citizens Against Government Waste
President Trump has made lowering drug prices and reducing healthcare costs for Americans a top priority of his second term, along with encouraging more biopharmaceutical investment and innovation in the U.S. Citizens Against Government Waste suggests that he can achieve both objectives without imposing price controls, which includes Most Favored Nation (MFN) polices, reforming the […]| Citizens Against Government Waste
The CBO report should spur lawmakers to make long overdue reforms to the 340B program, including a clear patient definition.| Citizens Against Government Waste
The federal 340B Drug Pricing Program was intended to provide discounts on drugs to patients but the lack of a clear intent and patient definition, along with| Citizens Against Government Waste
On January 20, a new administration began addressing our nation’s pressing problems, including health care costs. Drug costs are unaffordable for many, especially those in small communities with limited access to medical care. Working-class families understandably feel powerless against big, profit-hungry pharmaceutical corporations. They are often forced to decide between taking needed medications or paying […]| The Hayride
In their ongoing quest to lower prescription drug prices, some states are forcing drugmakers to continue to sell cheaper medications to thousands of pharmacies through a federal drug-discount program.| Stateline
MHA staff attended the Regional 340B Roundtable Aug. 7 in Florence, IN to join colleagues from the Indiana Hospital Association, Ohio Hospital Association, Kentucky Hospital Association and endorsed business partner, SunRx, to share best practices for successful 340B administration and advocacy. Nearly 200 340B experts gathered from the four states…| MHA | Michigan Health & Hospital Association
Weekly news and updates from the MHA.| MHA | Michigan Health & Hospital Association
